Interactions of helminths with macrophages: therapeutic potential for inflammatory intestinal disease

References

• Murray PJ, Allen J, Biswas S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines (vol 41, pg 14, 2014). Immunity. 2014;41(2):339–340.
   Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
   PubMedGoogle Scholar
• Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 2011;7(5):e1002003.
   PubMed Web of Science ®Google Scholar
• Nair MG, Gallagher IJ, Taylor MD, et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun. 2005;73(1):385–394.
   PubMed Web of Science ®Google Scholar
• Kreider T, Anthony RM, Urban JF, et al. Alternatively activated macrophages in helminth infections. Curr Opin Immunol. 2007;19(4):448–453.
   PubMed Web of Science ®Google Scholar
• Van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260.
   PubMed Web of Science ®Google Scholar
• Lee SH, Starkey PM, Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med. 1985;161(3):475–489.
   PubMed Web of Science ®Google Scholar
• Bain CC, Bravo-Blas A, Scott CL, et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol. 2014;15(10):929–937.
   PubMed Web of Science ®Google Scholar
• Bain CC, Scott CL, Uronen-Hansson H, et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013;6(3):498–510.
   PubMed Web of Science ®Google Scholar
• Tamoutounour S, Henri S, Lelouard H, et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol. 2012;42(12):3150–3166.
   PubMed Web of Science ®Google Scholar
• Schridde A, Bain CC, Mayer JU, et al. Tissue-specific differentiation of colonic macrophages requires TGFβ receptor-mediated signaling. Mucosal Immunol. 2017;10(6):1387–1399.
   PubMed Web of Science ®Google Scholar
• Smythies LE, Maheshwari A, Clements R, et al. Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J Leukoc Biol. 2006;80(3):492–499.
   PubMed Web of Science ®Google Scholar
• Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115(1):66–75.
   PubMed Web of Science ®Google Scholar
• Denning TL, Wang Y-C, Patel SR, et al. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol. 2007;8(10):1086–1094.
   PubMed Web of Science ®Google Scholar
• Kühn R, Löhler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75(2):263–274.
   PubMed Web of Science ®Google Scholar
• Zigmond E, Bernshtein B, Friedlander G, et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity. 2014;40(5):720–733.
   PubMed Web of Science ®Google Scholar
• Weber B, Saurer L, Schenk M, et al. CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur J Immunol. 2011;41(3):773–779.
   PubMed Web of Science ®Google Scholar
• Schulz O, Jaensson E, Persson EK, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med. 2009;206(13):3101–3114.
   PubMed Web of Science ®Google Scholar
• Mowat AM, Scott CL, Bain CC. Barrier-tissue macrophages: functional adaptation to environmental challenges. Nat Med. 2017;23(11):1258–1270.
   PubMed Web of Science ®Google Scholar
• Zigmond E, Varol C, Farache J, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012;37(6):1076–1090.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349–361.
   PubMed Web of Science ®Google Scholar
• Rani R, Smulian AG, Greaves DR, et al. TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol. 2011;41(7):2000–2009.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–5777.
   PubMed Web of Science ®Google Scholar
• Makita N, Hizukuri Y, Yamashiro K, et al. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. Int Immunol. 2015;27(3):131–141.
   PubMed Web of Science ®Google Scholar
• Dileepan KN, Page JC, Li Y, et al. Direct activation of murine peritoneal-macrophages for nitric-oxide production and tumor-cell killing by interferon-gamma. J Interferon Cytokine Res. 1995;15(5):387–394.
   PubMed Web of Science ®Google Scholar
• Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell-function in mice with disrupted interferon-gamma genes. Science. 1993;259(5102):1739–1742.
   PubMed Web of Science ®Google Scholar
• Shaughnessy LM, Swanson JA. The role of the activated macrophage in clearing Listeria monocytogenes infection. Front Biosci. 2007;12:2683–2692.
   PubMed Web of Science ®Google Scholar
• Hagemann T, Lawrence T, McNeish I, et al. “Re-educating” tumor-associated macrophages by targeting NF-kappa B. J Exp Med. 2008;205(6):1261–1268.
   PubMed Web of Science ®Google Scholar
• Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49.
   PubMed Web of Science ®Google Scholar
• Vogel, D.Y.S., Vereyken EJ, Glim JE, et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 2013;10:12.
   PubMed Web of Science ®Google Scholar
• Lissner D, Schumann M, Batra A, et al. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21(6):1297–1305.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol. 2017;10(1):58.
   PubMed Web of Science ®Google Scholar
• Gundra UM, Girgis NM, Ruckerl D, et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood. 2014;123(20):e110–22.
   PubMed Web of Science ®Google Scholar
• Gundra UM, Girgis NM, Gonzalez MA, et al. Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation. Nat Immunol. 2017;18(6):642–653.
   PubMed Web of Science ®Google Scholar
• Gray MJ, Poljakovic M, Kepka-Lenhart D, et al. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene. 2005;353(1):98–106.
   PubMed Web of Science ®Google Scholar
• Stütz AM, Pickart LA, Trifilieff A, et al. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J Immunol. 2003;170(4):1789–1796.
   PubMed Web of Science ®Google Scholar
• Welch JS, Escoubet-Lozach L, Sykes DB, et al. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem. 2002;277(45):42821–42829.
   PubMed Web of Science ®Google Scholar
• Dewals BG, Marillier RG, Hoving JC, et al. IL-4Rα-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl Trop Dis. 2010;4(5):e689.
   PubMed Web of Science ®Google Scholar
• El Kasmi KC, Qualls JE, Pesce JT, et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol. 2008;9(12):1399–1406.
   PubMed Web of Science ®Google Scholar
• Nair MG, Du Y, Perrigoue JG, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med. 2009;206(4):937–952.
   PubMed Web of Science ®Google Scholar
• Pesce JT, Grigoriu S, Kim Y, et al. Retnla (Relm alpha/Fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog. 2009;5(4):15.
   Web of Science ®Google Scholar
• Arora M, Chen L, Paglia M, et al. Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proc Natl Acad Sci USA. 2006;103(20):7777–7782.
   PubMed Web of Science ®Google Scholar
• Sutherland TE, Logan N, Rückerl D, et al. Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage. Nat Immunol. 2014;15(12):1116–1125.
   PubMed Web of Science ®Google Scholar
• Thompson RW, Pesce JT, Ramalingam T, et al. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog. 2008;4(3):e1000023.
   PubMed Web of Science ®Google Scholar
• Pesce JT, Grigoriu S, Kim Y, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5(4):15.
   Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816–827.
   PubMed Web of Science ®Google Scholar
• Yogo Y, Chase MA, Senft AP, et al. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. Respir Res. 2009;10:80.
   PubMed Web of Science ®Google Scholar
• Anthony RM, Urban JF, Alem F, et al. Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med. 2006;12(8):955–960.
   PubMed Web of Science ®Google Scholar
• Herbert DR, Hölscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20(5):623–635.
   PubMed Web of Science ®Google Scholar
• Zhao AP, Urban JF, Anthony RM, et al. Th2 cytokine-induced alterations in lntestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology. 2008;135(1):217–225.
   PubMed Web of Science ®Google Scholar
• Chen F, Wu W, Millman A, et al. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol. 2014;15(10):938–946.
   PubMed Web of Science ®Google Scholar
• Bowcutt R, Bell LV, Little M, et al. Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. Parasite Immunol. 2011;33(7):411–420.
   PubMed Web of Science ®Google Scholar
• Little MC, Hurst RJM, Else KJ. Dynamic changes in macrophage activation and proliferation during the development and resolution of intestinal inflammation. J Immunol. 2014;193(9):4684–4695.
   PubMed Web of Science ®Google Scholar
• Knipper JA, Willenborg S, Brinckmann J, et al. Interleukin-4 receptor alpha signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity. 2015;43(4):803–816.
   PubMed Web of Science ®Google Scholar
• Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy in Crohn’s disease. Gut. 2005;54(1):87–90.
   PubMed Web of Science ®Google Scholar
• Croese J, O’neil J, Masson J, et al. A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors. Gut. 2006;55(1):136–137.
   PubMed Web of Science ®Google Scholar
• Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128(4):825–832.
   PubMed Web of Science ®Google Scholar
• Croese J, Giacomin P, Navarro S, et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol. 2015;135(2):508–516.
   PubMed Web of Science ®Google Scholar
• Reardon C, Sanchez A, Hogaboam CM, et al. Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis. Infect Immun. 2001;69(7):4417–4423.
   PubMed Web of Science ®Google Scholar
• Cançado GG, Fiuza JA, De Paiva NCN, et al. Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice. Inflamm Bowel Dis. 2011;17(11):2275–2286.
   PubMed Web of Science ®Google Scholar
• Garg SK, Croft AM, Bager P. Helminth therapy (worms) for induction of remission in inflammatory bowel disease. Cochrane Database Syst Rev. 2014;(1):CD009400.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Elliott DE, Weinstock J, et al. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn’s disease. Aliment Pharmacol Ther. 2013;38(3):255–263.
   PubMed Web of Science ®Google Scholar
• Kradin RL, Badizadegan K, Auluck P, et al. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006;130(5):718–720.
   PubMed Web of Science ®Google Scholar
• Shepherd C, Navarro S, Wangchuk P, et al. Identifying the immunomodulatory components of helminths. Parasite Immunol. 2015;37(6):293–303.
   PubMed Web of Science ®Google Scholar
• Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol. 2009;167(1):1–11.
   PubMed Web of Science ®Google Scholar
• Marshall FA, Grierson AM, Garside P, et al. ES-62, an immunomodulator secreted by filarial nematodes, suppresses clonal expansion and modifies effector function of heterologous antigen-specific T cells in vivo. J Immunol. 2005;175(9):5817–5826.
   PubMed Web of Science ®Google Scholar
• Johnston MJG, Wang A, Catarino MED, et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun. 2010;78(3):1364–1375.
   PubMed Web of Science ®Google Scholar
• Zhu JF, Xu Z, Chen X, et al. Parasitic antigens alter macrophage polarization during Schistosoma japonicum infection in mice. Parasit Vectors. 2014;7:9.
   PubMed Web of Science ®Google Scholar
• Everts B, Hussaarts L, Driessen NN, et al. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med. 2012;209(10):1753–1767.
   PubMed Web of Science ®Google Scholar
• Mountford AP, Wilson RA. FRACTIONATION OF SCHISTOSOME ANTIGENS BY HIGH-PERFORMANCE ELECTROPHORETIC CHROMATOGRAPHY AND THEIR SCREENING FOR THE ABILITY TO INDUCE TH1 LYMPHOCYTE ACTIVITY. J Immunol Methods. 1993;160(2):237–244.
   PubMed Web of Science ®Google Scholar
• Truscott M, Evans DA, Gunn M, et al. Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of retnla expression and secretion. Infect Immun. 2013;81(1):133–142.
   PubMed Web of Science ®Google Scholar
• Schnoeller C, Rausch S, Pillai S, et al. Helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-Producing macrophages. J Immunol. 2008;180(6):4265–4272.
   PubMed Web of Science ®Google Scholar
• Klotz C, Ziegler T, Figueiredo AS, et al. A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog. 2011;7(1):17.
   Web of Science ®Google Scholar
• Ziegler T, Rausch S, Steinfelder S, et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. J Immunol. 2015;194(4):1555–1564.
   PubMedGoogle Scholar
• Danilowicz-Luebert E, Steinfelder S, Kühl AA, et al. A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol. 2013;43(3–4):201–210.
   PubMed Web of Science ®Google Scholar
• Aira N, Andersson A-M, Singh SK, et al. Species dependent impact of helminth-derived antigens on human macrophages infected with Mycobacterium tuberculosis: direct effect on the innate anti-mycobacterial response. PLoS Negl Trop Dis. 2017;11(2):e0005390.
   PubMed Web of Science ®Google Scholar
• Van den Bossche J, Baardman J, Otto NA, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 2016;17(3):684–696.
   PubMed Web of Science ®Google Scholar
• Goodridge HS, Wilson EH, Harnett W, et al. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol. 2001;167(2):940–945.
   PubMed Web of Science ®Google Scholar
• Goodridge HS, Marshall FA, Wilson EH, et al. In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology. 2004;113(4):491–498.
   PubMed Web of Science ®Google Scholar
• Almeida S, Nejsum P, Williams AR. Modulation of human macrophage activity by Ascaris antigens is dependent on macrophage polarization state. Immunobiology. 2018;223(4–5):405–412.
   PubMed Web of Science ®Google Scholar
• Hoeksema MA, Laan LC, Postma JJ, et al. Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling. Faseb J. 2016;30(8):2826–2836.
   PubMed Web of Science ®Google Scholar
• Harnett W, Harnett MM, Byron O. Structural/functional aspects of ES-62 - A secreted immunomodulatory phosphorylcholine-containing filarial nematode glycoprotein. Curr Protein Pept Sci. 2003;4(1):59–71.
   PubMed Web of Science ®Google Scholar
• Harnett W, Goodridge HS, Allen JM, et al. Receptor usage by the Acanthocheilonema viteae-derived immunomodulator, ES-62. Exp Parasitol. 2012;132(1):97–102.
   PubMed Web of Science ®Google Scholar
• Al-Riyami L, Pineda MA, Rzepecka J, et al. Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis. J Med Chem. 2013;56(24):9982–10002.
   PubMed Web of Science ®Google Scholar
• Miao X, Leng X, Zhang Q. The current state of nanoparticle-induced macrophage polarization and reprogramming research. Int J Mol Sci. 2017;18(2):336.
   Web of Science ®Google Scholar
• Moss DM, Curley P, Kinvig H, et al. The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. Expert Rev Gastroenterol Hepatol. 2018;12(3):223–236.
   PubMed Web of Science ®Google Scholar
• Rios de la Rosa JM, Tirella A, Gennari A, et al. The CD44-mediated uptake of hyaluronic acid-based carriers in macrophages. Adv Healthc Mater. 2017;6(4):1601012.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhuang X, Deng Z-B, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014;22(3):522–534.
   PubMed Web of Science ®Google Scholar
• Johnston CJC, Smyth DJ, Kodali RB, et al. A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells. Nat Commun. 2017;8(1):1741.
   PubMedGoogle Scholar